Report #2853166

Received Aug 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 5 yrs
State: FL
Recovered: Unknown
Vaccinated: Jul 28, 2025
Onset: Jul 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	HR4RB	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Adult presentation given to pediatric patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 5-year-old female patient who received HAV (Havrix) (batch number HR4RB, expiry date 18-DEC-2025) for prophylaxis. On 28-JUL-2025, the patient received Havrix. On 28-JUL-2025, an unknown time after receiving Havrix, the patient experienced adult product administered to child (Verbatim: Adult presentation given to pediatric patient). The outcome of the adult product administered to child was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 28-JUL-2025 Other HCP reported that they administered an adult presentation of Havrix to a 5-year-old patient on July 28th, 2025, which led to adult product administered to child.